Nuvalent, INC. (NUVL) — 8-K Filings

8-K Filings (19)

• Nuvalent, Inc. Files 8-K for Other Events — Apr 7, 2026 Risk: low
  Nuvalent, Inc. filed an 8-K on April 7, 2026, to report other events. The filing does not contain specific financial figures or new material agreements, but ser
• 8-K Filing — Dec 16, 2025
• Nuvalent, Inc. Reports Director and Officer Changes — Dec 10, 2025 Risk: medium
  Nuvalent, Inc. filed an 8-K on December 10, 2025, reporting changes effective December 9, 2025. The filing pertains to the departure of directors or certain off
• Nuvalent Enters Material Definitive Agreement — Nov 20, 2025 Risk: medium
  Nuvalent, Inc. announced on November 18, 2025, that it has entered into a material definitive agreement. The company, incorporated in Delaware with its principa
• 8-K Filing — Nov 17, 2025
• Nuvalent Files 8-K for Other Events — Sep 22, 2025 Risk: medium
  Nuvalent, Inc. filed an 8-K on September 22, 2025, to report other events. The filing does not contain specific details about the nature of these events, dollar
• Nuvalent, Inc. Files 8-K — Jul 21, 2025 Risk: low
  Nuvalent, Inc. filed an 8-K on July 21, 2025, reporting other events. The filing does not contain specific details about the nature of these events, dollar amou
• BioNTech to Acquire Nuvalent for $1.1 Billion — Jun 24, 2025 Risk: medium
  Nuvalent, Inc. announced on June 24, 2025, that it has entered into a definitive agreement to be acquired by a subsidiary of BioNTech SE. The transaction is val
• Nuvalent Appoints New Director to Board — Jun 20, 2025 Risk: low
  Nuvalent, Inc. announced on June 18, 2025, a change in its board of directors. Specifically, Dr. R. Brad Evans has been appointed as a Class II Director, effect
• Nuvalent Reports Director Departure, New CMO Appointment — Jun 10, 2025 Risk: medium
  On June 9, 2025, Nuvalent, Inc. filed an 8-K to report changes in its board of directors and executive compensation. Specifically, the company announced the dep
• Nuvalent Appoints New Director to Board — Apr 17, 2025 Risk: low
  Nuvalent, Inc. announced on April 11, 2025, a change in its board of directors. Dr. R. Brad Evans has been appointed as a Class II Director, effective immediate
• Nuvalent Files 8-K: Other Events & Exhibits — Jan 14, 2025 Risk: low
  Nuvalent, Inc. filed an 8-K on January 14, 2025, reporting an event on January 13, 2025. The filing is a current report under Section 13 or 15(d) of the Securit
• Nuvalent Files 8-K on Executive Changes and Financials — Dec 9, 2024 Risk: low
  Nuvalent, Inc. filed an 8-K on December 9, 2024, reporting on the departure of directors or certain officers, election of directors, appointment of certain offi
• Nuvalent Enters Material Definitive Agreement — Sep 17, 2024 Risk: medium
  Nuvalent, Inc. announced on September 16, 2024, that it entered into a material definitive agreement. The company also reported other events and filed financial
• Nuvalent Files 8-K: Other Events & Financials — Sep 16, 2024 Risk: low
  Nuvalent, Inc. filed an 8-K on September 16, 2024, reporting on other events and financial statements. The filing date for the report is September 14, 2024. The
• Nuvalent Appoints Dr. Arvind Sood as Chief Medical Officer — Jul 22, 2024 Risk: medium
  On July 22, 2024, Nuvalent, Inc. announced the appointment of Dr. Arvind Sood as Chief Medical Officer. Dr. Sood brings extensive experience in oncology drug de
• Nuvalent Files 8-K on Shareholder Vote Matters — Jun 14, 2024 Risk: low
  Nuvalent, Inc. filed an 8-K on June 14, 2024, reporting on matters submitted to a vote of security holders on June 12, 2024. The filing details the company's co
• Nuvalent Appoints New Chief Medical Officer — May 16, 2024 Risk: medium
  On May 16, 2024, Nuvalent, Inc. announced the appointment of Dr. R. Christopher L. Smith as Chief Medical Officer, effective May 20, 2024. Dr. Smith brings exte
• Nuvalent 8-K Signals Update on Financial Condition — Jan 9, 2024
  Nuvalent, Inc. filed an 8-K on January 9, 2024, reporting an event that occurred on January 8, 2024, related to 'Results of Operations and Financial Condition'

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX